This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Nov 16;306(19):2153-5.

doi: 10.1001/jama.2011.1687.

High-density lipoprotein cholesterol as the Holy Grail

Christopher P Cannon

PMID: 22089726
DOI: 10.1001/jama.2011.1687

Editorial

High-density lipoprotein cholesterol as the Holy Grail

Christopher P Cannon. JAMA. 2011.

. 2011 Nov 16;306(19):2153-5.

doi: 10.1001/jama.2011.1687.

Author

Christopher P Cannon

PMID: 22089726
DOI: 10.1001/jama.2011.1687

No abstract available

PubMed Disclaimer

Comment on

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE. Nicholls SJ, et al. JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649. JAMA. 2011. PMID: 22089718 Clinical Trial.

Similar articles

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE. Nicholls SJ, et al. JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649. JAMA. 2011. PMID: 22089718 Clinical Trial.
Treating high-density lipoprotein cholesterol: a return to inhibition of cholesteryl ester transfer protein?
Duriez P. Duriez P. Curr Atheroscler Rep. 2008 Jun;10(3):177-9. doi: 10.1007/s11883-008-0027-x. Curr Atheroscler Rep. 2008. PMID: 18489843 No abstract available.
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.
Hovingh GK, Kastelein JJ, van Deventer SJ, Round P, Ford J, Saleheen D, Rader DJ, Brewer HB, Barter PJ. Hovingh GK, et al. Lancet. 2015 Aug 1;386(9992):452-60. doi: 10.1016/S0140-6736(15)60158-1. Epub 2015 Jun 2. Lancet. 2015. PMID: 26047975 Clinical Trial.
Anacetrapib: a new weapon against dyslipidemia.
Aperis G, Paliouras C, Tsampikaki E, Papakonstantinou N, Alivanis P. Aperis G, et al. Curr Clin Pharmacol. 2011 Nov;6(4):227-35. doi: 10.2174/157488411798375949. Curr Clin Pharmacol. 2011. PMID: 22082322 Review.
The treatment of dyslipidemia--what's left in the pipeline?
Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. ChemMedChem. 2008 Feb;3(2):206-21. doi: 10.1002/cmdc.200700165. ChemMedChem. 2008. PMID: 17963209 Review.

See all similar articles

Cited by

Does the Prevalence of Dyslipidemias Differ between Newfoundland and the Rest of Canada? Findings from the Electronic Medical Records of the Canadian Primary Care Sentinel Surveillance Network.
Asghari S, Aref-Eshghi E, Hurley O, Godwin M, Duke P, Williamson T, Mahdavian M. Asghari S, et al. Front Cardiovasc Med. 2015 Feb 2;2:1. doi: 10.3389/fcvm.2015.00001. eCollection 2015. Front Cardiovasc Med. 2015. PMID: 26664873 Free PMC article.
HDL, Atherosclerosis, and Emerging Therapies.
Hafiane A, Genest J. Hafiane A, et al. Cholesterol. 2013;2013:891403. doi: 10.1155/2013/891403. Epub 2013 May 28. Cholesterol. 2013. PMID: 23781332 Free PMC article.
Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.
Aslibekyan S, Straka RJ, Irvin MR, Claas SA, Arnett DK. Aslibekyan S, et al. Expert Rev Cardiovasc Ther. 2013 Mar;11(3):355-64. doi: 10.1586/erc.12.134. Expert Rev Cardiovasc Ther. 2013. PMID: 23469915 Free PMC article. Review.
HDL cholesterol and cardiovascular outcomes: what is the evidence?
Rubenfire M, Brook RD. Rubenfire M, et al. Curr Cardiol Rep. 2013 Apr;15(4):349. doi: 10.1007/s11886-013-0349-3. Curr Cardiol Rep. 2013. PMID: 23420445 Review.
Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.
Liu S, Mistry A, Reynolds JM, Lloyd DB, Griffor MC, Perry DA, Ruggeri RB, Clark RW, Qiu X. Liu S, et al. J Biol Chem. 2012 Oct 26;287(44):37321-9. doi: 10.1074/jbc.M112.380063. Epub 2012 Sep 7. J Biol Chem. 2012. PMID: 22961980 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information